Skip to main content

LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer



This is really great!

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to astudy published August 21 in the Journal of the National Cancer Institute.

Metastasis is a main contributor to mortality in cancer patients.

Patients with “triple negative” breast cancer (tumour cells that are hormone receptor negative and express normal levels of the HER2 oncogene) are known to be at high risk for metastatic progression.

In addition, breast and prostate cancers are known for having variable but possibly long periods of dormancy, where the disease is silent.

Factors inducing or breaking a dormant state are poorly understood, but extending dormancy is considered a therapeutic goal.

To determine the effects of LPA1 inhibition on metastatic dormancy, Jean-Claude A. Marshall, MSc., Ph.D. of the Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, and colleagues analyzed primary tumour size, distant metastases and their molecular characteristics in two model systems of aggressive “triple negative” breast cancer metastasis, the murine 4T1 mammary carcinoma model and human MDA-MB-231 human breast carcinoma model. Debio-0719 or shRNA knockdown of LPA1 significantly inhibited metastasis formation without affecting primary tumour size.

Tumour cells found in distant organs, such as the lungs and liver of Debio-0719 treated mice, had ceased proliferation and exhibited other molecular hallmarks of dormancy.
LPA1 inhibition represents one of the first compounds to induce dormancy in metastatic sites in triple negative breast cancer.

The authors point out that LPA1 inhibition had no effect on the growth of the primary tumors in either model system. As such, it would not normally be considered further for drug development.
Their data suggest that alternative drug development approaches may identify compounds with novel activities, such as metastatic dormancy.

The authors point out that their study did not determine the duration of tumour dormancy, and that Debio-0719 and other LPA1 inhibitors should be tested in additional model systems.

However, they conclude: “With such inhibitors in hand, the interaction of dormancy pathways and standard of care therapeutics, radiation therapy, patient stress, and other important factors can be determined to develop a deeper picture of potential preventative and therapeutic scenarios.”

Popular posts from this blog

"Hard nipples" - areola or nipple skin

Someone once wrote"...when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this varies with ind…

Seinfeld star ⭐️ Julia Louis - Dreyfus and breast cancer

Jerry Seinfeld says Julia Louis-Dreyfus is in great spirits following the actress' final round of chemotherapy treatment. While attending an event in for Bob Roth's new book, Strength in Stillness: The Power of Transcendental Meditation, at Joe's Pub at The Public in New York City on Tuesday night, the Seinfeld alum told ET that his former co-star is on the mend. "I talk to her all the time," the 63-year-old comedian revealed. "She's doing great." Louis-Dreyfus revealed her breast cancer diagnosis last fall, and she finished up her last round of chemotherapy this past month. Her sons, Henry and Charlie, even made her a hilarious video of themselves lip-syncing and dancing to Michael Jackson's "Beat It" to celebrate the big day. The 57-year-old actress' latest Instagram post, shared on Jan. 29, paid homage to Seinfeld. Louis-Dreyfus took a photo of the back of a picture frame she found at her late father's house, the back of wh…

The four stages of breast development

In Stage 1 shows the flat breasts of childhood. By Stage 2, breast buds are formed as milk ducts and fat tissue develop. In Stage 3, the breast become round and full, and the areola darkens. Stage 4 shows fully mature breasts.
(Illustration by GGS Information Services.) period begins. Usually these signs are accompanied by the appearance of pubic hair and hair under the arms.
Once ovulation and menstruation begin, the maturing of the breasts begins with the formation of secretory glands at the end of the milk ducts. The breasts and duct system continue to grow and mature with the development of many glands and lobules. The rate at which breasts grow varies significantly and is different for each young woman. Breast development occurs in five stages:
Stage One: In preadolescence, the breasts are flat and only the tip of the nipple is raised.Stage Two: Buds appear, breast and nipple are raised, fat tissue begins to form and the areola (dark area of skin that surrounds the nipple) enlarge…